A federal judge in Trenton has ordered that a General Electric Co. subsidiary pay $11.3 million for making false advertising claims about a competitor’s X-ray contrast agent.
U.S. District Judge Freda Wolfson held on March 25 that Amersham Health Inc., a British company with U.S. offices in Princeton that was bought by GE Healthcare in 2004, violated the Lanham Act with false and misleading claims that its contrast agent, used to improve X-ray quality, was superior to one made by Bracco Diagnostics Inc. of Princeton.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
